Do not open this window today
ENG
Providing innovation and pioneering technology based on relentless focus on quality
Approval of the HSC on our products f...
As a manufacturer of BIOCREDIT COVID-19 Ag – Nasopharyngeal or Nasal, Rapigen Inc. hereby declares that: The Health Security Committee agreed on the EU common list of both BIOCREDIT COVID-19 Ag ...
2022.10.24
Celebrating Rapigen’s 20th Anniversary
To mark this historic milestone, Rapigen Head Office in Suwon factory hosted a special event to celebrate its 20th anniversary with Rapigen’s family members. Featured activities included a specia...
2022.06.17
Rapigen to work with Eunpyeong St. Ma...
Rapigen and Eunpyeong St. Mary’s Hospital pose for a photo after signing a business agreement for joint research and development on Medical devices for In-Vitro Diagnosis in preparation for pos...
2022.05.12
Authorization given to add Rapigen’s ...
The BIOCREDIT COVID-19 Ag Home Test met the selection criteria and was forwarded for full evaluation by Science and Technical Advisory.Upon full evaluation, the BIOCREDIT COVID-19 Ag Home Test ...
2022.03.16
More
Our experts will get in touch with you shortly.
Inquire